Longitudinal reduction defect of tibia, bilateral
ICD-10 Q72.53 is a billable code used to indicate a diagnosis of longitudinal reduction defect of tibia, bilateral.
Longitudinal reduction defect of the tibia is a congenital malformation characterized by the underdevelopment or absence of the tibia, leading to significant limb length discrepancies and functional impairments. In bilateral cases, both tibiae are affected, which can result in severe gait abnormalities and challenges in mobility. This condition is often associated with other congenital anomalies, including clubfoot, limb reduction defects, and scoliosis. The etiology may involve genetic factors, environmental influences, or a combination of both. Diagnosis typically occurs through physical examination and imaging studies, such as X-rays, which reveal the extent of the tibial reduction. Management may include orthopedic interventions, such as bracing or surgical procedures, to improve function and alignment. Early intervention is crucial for optimizing outcomes and facilitating mobility in affected children.
Detailed growth and development assessments, physical examination findings, and treatment plans must be documented.
A pediatric patient presents with bilateral tibial reduction defects and associated clubfoot requiring orthopedic intervention.
Consideration of developmental milestones and the impact of the defect on mobility and daily activities.
Genetic testing results, family history of congenital conditions, and any syndromic associations must be documented.
A child with bilateral tibial reduction defects undergoes genetic counseling to assess for syndromic causes.
Understanding the genetic basis of congenital malformations and the implications for family planning.
Used in surgical correction of tibial deformities.
Surgical notes detailing the procedure and indications.
Orthopedic specialists must document the rationale for surgery.
Accurate coding of Q72.53 is crucial for ensuring appropriate treatment planning, resource allocation, and understanding the epidemiology of congenital limb defects. It also impacts reimbursement and the quality of care provided to affected children.
